Abstract
Plaque disruption and subsequent thrombus formation play a critical role in the clinical manifestations of atherothrombosis. Vulnerable lesions are characterized by the existence of core rich in lipid, macrophages and tissue factor (TF). Plaque disruption facilitates the interaction between flowing blood with the inner components (TF) of disrupted atherosclerotic lesions triggering the coagulation cascade. TF, thrombin, platelets, fibrin and inflammatory cells are involved in this process of acute thrombus formation. This pathologic process is significantly accelerated by several "cardiovascular risk factors" such as diabetes, smoking, dyslipemia, etc. We will review on the role of TF, plaque cell apoptosis and blood thrombogenicity acting as a thread of inflammatory and prothrombotic mediators. We will also review the role of activated platelets as source for pro-inflammatory cytokines and enunciation of thrombotic process. Overall, we will try to emphasize the most recent understanding of the concepts involved in the interaction between inflammation and coagulation within the setting of atherothrombotic disease.
Keywords: Atherothrombosis, atherosclerosis, tissue factor, thrombin, platelet, apoptosis, inflammation, thrombosis, plaque, vulnerable plaque
Current Molecular Medicine
Title: Links Between Inflammation and Thrombogenicity in Atherosclerosis
Volume: 6 Issue: 5
Author(s): J. F. Viles-Gonzalez, V. Fuster and J. J. Badimon
Affiliation:
Keywords: Atherothrombosis, atherosclerosis, tissue factor, thrombin, platelet, apoptosis, inflammation, thrombosis, plaque, vulnerable plaque
Abstract: Plaque disruption and subsequent thrombus formation play a critical role in the clinical manifestations of atherothrombosis. Vulnerable lesions are characterized by the existence of core rich in lipid, macrophages and tissue factor (TF). Plaque disruption facilitates the interaction between flowing blood with the inner components (TF) of disrupted atherosclerotic lesions triggering the coagulation cascade. TF, thrombin, platelets, fibrin and inflammatory cells are involved in this process of acute thrombus formation. This pathologic process is significantly accelerated by several "cardiovascular risk factors" such as diabetes, smoking, dyslipemia, etc. We will review on the role of TF, plaque cell apoptosis and blood thrombogenicity acting as a thread of inflammatory and prothrombotic mediators. We will also review the role of activated platelets as source for pro-inflammatory cytokines and enunciation of thrombotic process. Overall, we will try to emphasize the most recent understanding of the concepts involved in the interaction between inflammation and coagulation within the setting of atherothrombotic disease.
Export Options
About this article
Cite this article as:
Viles-Gonzalez F. J., Fuster V. and Badimon J. J., Links Between Inflammation and Thrombogenicity in Atherosclerosis, Current Molecular Medicine 2006; 6 (5) . https://dx.doi.org/10.2174/156652406778018707
DOI https://dx.doi.org/10.2174/156652406778018707 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Development of Specific Radiopharmaceuticals for Infection Imaging by Targeting Infectious Micro-organisms
Current Pharmaceutical Design Nanoparticle-Delivered Quercetin for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Nanocrystal Technology in the Delivery of Poorly Soluble Drugs: An Overview
Current Drug Delivery Hydroxysafflor Yellow A Attenuates Renal Ischemia- Reperfusion Injury in a Rat Model
Letters in Drug Design & Discovery Novel Antiinflammatory and Antiinfective Agents
Anti-Infective Agents in Medicinal Chemistry Recent Advances in the Synthesis of Sphingosine and Phytosphingosine, Molecules of Biological Significance
Current Organic Chemistry Cytoprotective Strategy Against Pulmonary Fibrosis
Drug Design Reviews - Online (Discontinued) Prevention and Therapeutic Strategies of Thromboembolic Events in Patients with Inflammatory Bowel Diseases: A Report of Three Cases
Current Drug Targets Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a Detoxifying Enzyme
Current Medicinal Chemistry Subject index to volume 3
Current Molecular Medicine Synthesis and Evaluation of Tricyclic Dipyrido Diazepinone Derivatives as Inhibitors of Secretory Phospholipase A2 with Anti-Inflammatory Activity
Current Topics in Medicinal Chemistry The Target of Regulating The ATP-binding Cassette A1 Protein (ABCA1): Promoting ABCA1-Mediated Cholesterol Efflux in Different Cells
Current Pharmaceutical Biotechnology ADAM Metalloproteinases as Potential Drug Targets
Current Medicinal Chemistry Editorial [Immunogenicity of Biotherapeutics: A Need for Consensus on Flexibility of Approach (Guest Editor: Stewart Barker)]
Current Drug Safety The CX3C-Chemokine Fractalkine in Kidney Diseases
Mini-Reviews in Medicinal Chemistry Overexpressing Runx2 of BMSCs Improves the Repairment of knee Cartilage Defects
Current Gene Therapy The Quality of Life and Professional Future among Tunisian Workers Suffering from Occupational Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Cubic Phases, Cubosomes and Ethosomes for Cutaneous Application
Current Pharmaceutical Design Redox Systems, Antioxidants and Sarcopenia
Current Protein & Peptide Science Pathophysiology of NASH: Perspectives for a Targeted Treatment
Current Pharmaceutical Design